Background: Cancer precision medicine is an effective strategy to fight cancers by bridging genomics and drug discovery to provide specific treatment for patients with different genetic characteristics. Although some public databases and modelling frameworks have been developed through studies on drug response, most of them only considered the ramifications of the drug on the cell line and the effects on the patient still require a huge amount of work to integrate data from various databases and calculations, especially concerning precision treatment. Furthermore, not only efficacy but also the adverse effects of drugs on patients should be taken into account during cancer treatment. However, the adverse effects as essential indicators of d...
With the advancement of high throughput technologies, many repositories of the genome, proteome, tra...
Abstract BACKGROUND: Drugs for targeted therapies are primarily Small Molecules Inhibitors (SMIs),...
Abstract BACKGROUND: Drugs for targeted therapies are primarily Small Molecules Inhibitors (SMIs),...
A critical overview of recent clinical trials in cancer is presented focused on signaling pathways b...
Introduction: Network pharmacology has emerged as a forefront and hotspot in anti-cancer. Traditiona...
Table S1. Drug classes in DEPO (database of evidence for precision oncology). Table S2. Sensitive dr...
Accurate identification of molecular targets of disease plays an important role in diagnosis, progno...
Article: Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia Cancer...
A critical overview of recent clinical trials in cancer is presented focused on signaling pathways b...
Article: Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia Cancer...
Background: Icaritin is a natural product with a wide range of anti-tumor effects. However, its anti...
Precision medicine is at the forefront of innovation in cancer care. With the development of technol...
Pancreatic ductal adenocarcinoma (PDAC) is a tumor with an extremely poor prognosis, predominantly d...
Cancer is a heterogeneous disease afflicting millions of people of all ages and their families world...
Cancer is a heterogeneous disease afflicting millions of people of all ages and their families world...
With the advancement of high throughput technologies, many repositories of the genome, proteome, tra...
Abstract BACKGROUND: Drugs for targeted therapies are primarily Small Molecules Inhibitors (SMIs),...
Abstract BACKGROUND: Drugs for targeted therapies are primarily Small Molecules Inhibitors (SMIs),...
A critical overview of recent clinical trials in cancer is presented focused on signaling pathways b...
Introduction: Network pharmacology has emerged as a forefront and hotspot in anti-cancer. Traditiona...
Table S1. Drug classes in DEPO (database of evidence for precision oncology). Table S2. Sensitive dr...
Accurate identification of molecular targets of disease plays an important role in diagnosis, progno...
Article: Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia Cancer...
A critical overview of recent clinical trials in cancer is presented focused on signaling pathways b...
Article: Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia Cancer...
Background: Icaritin is a natural product with a wide range of anti-tumor effects. However, its anti...
Precision medicine is at the forefront of innovation in cancer care. With the development of technol...
Pancreatic ductal adenocarcinoma (PDAC) is a tumor with an extremely poor prognosis, predominantly d...
Cancer is a heterogeneous disease afflicting millions of people of all ages and their families world...
Cancer is a heterogeneous disease afflicting millions of people of all ages and their families world...
With the advancement of high throughput technologies, many repositories of the genome, proteome, tra...
Abstract BACKGROUND: Drugs for targeted therapies are primarily Small Molecules Inhibitors (SMIs),...
Abstract BACKGROUND: Drugs for targeted therapies are primarily Small Molecules Inhibitors (SMIs),...